Market Cap 1.97B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 6,366,100
Avg Vol 7,958,654
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 1%
Beta 1.14
Analysts Strong Sell
Price Target $10.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Jul. 21 at 4:03 AM
$ABCL "We need to build big companies, by whatever means. If we have big companies, we are an acquirer of technology. If we don't, we are a cheap branch plant for large multinationals in other jurisdictions." - Carl Hansen
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 21 at 4:01 AM
$ABCL $ABCL - buy low, sell high. Gobbling here.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 21 at 3:48 AM
$ABCL Biotech is dead money for most, but $ABCL quietly built a $650M war chest, dropped a key menopause drug into Phase 2, and just added another heavyweight to the board. While everyone’s still staring at AI, real assets with cash and catalysts are getting ignored.
0 · Reply
tradersunion353
tradersunion353 Jul. 21 at 2:17 AM
$ABCL so many fake posts about adding and loading anyhow phas2 data is leaked and bAd
0 · Reply
tradersunion353
tradersunion353 Jul. 21 at 1:49 AM
$ABCL guess was correct multiple posts on x indicate phase 2 data is leaked and bad
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 21 at 12:26 AM
$ABCL AbCellera just appointed two new directors. Their stocks options have an exercise price of $7.85 As an outsider, you can buy $ABCL at a lower price than these two insiders on the open market
0 · Reply
_StockRadars
_StockRadars Jul. 20 at 11:15 PM
$ABCL why dip ?
2 · Reply
Alpha_Owl
Alpha_Owl Jul. 20 at 11:02 PM
$ABCL Target Zone & Price Action We warned you. Price is sliding straight toward our projected target zone of $5.58 - $3.96. We are sitting back and waiting for the market to complete the flush. After-Hours Analysis Following today's regular session close at $5.80, after-hours trading shows tight stabilization around $5.80 - $5.82 on low volume. While the heavy selling pressure is pausing, technical momentum remains firmly bearish. Watch for a retest of the lower bound of our target zone before looking for any meaningful reversal setups. Closing bell is getting closer. Cash or fully invested? Good luck in the final hour.
0 · Reply
Odoji
Odoji Jul. 20 at 10:40 PM
$ABCL 💉
0 · Reply
SmartMoneyRadar
SmartMoneyRadar Jul. 20 at 10:29 PM
$ABCL is testing an important level here 👀 The stock is currently retesting the 50 MA, and this is the area where buyers need to show up. If this level holds and momentum starts building again, the next target I’m watching is the Wave 3 target around $10.19. No need to force the trade. I want to see confirmation from price action and volume before getting too aggressive. Watching closely to see if this turns into a continuation setup or just another bounce. What do you think? After-hours is active. Any earnings surprise today? Looking forward to your thoughts.
0 · Reply
Latest News on ABCL
AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 13 days ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 14 days ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 14 days ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 6 weeks ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 2 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 2 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 3 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 5 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 5 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 6 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 11 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


Stocktradesmoon
Stocktradesmoon Jul. 21 at 4:03 AM
$ABCL "We need to build big companies, by whatever means. If we have big companies, we are an acquirer of technology. If we don't, we are a cheap branch plant for large multinationals in other jurisdictions." - Carl Hansen
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 21 at 4:01 AM
$ABCL $ABCL - buy low, sell high. Gobbling here.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 21 at 3:48 AM
$ABCL Biotech is dead money for most, but $ABCL quietly built a $650M war chest, dropped a key menopause drug into Phase 2, and just added another heavyweight to the board. While everyone’s still staring at AI, real assets with cash and catalysts are getting ignored.
0 · Reply
tradersunion353
tradersunion353 Jul. 21 at 2:17 AM
$ABCL so many fake posts about adding and loading anyhow phas2 data is leaked and bAd
0 · Reply
tradersunion353
tradersunion353 Jul. 21 at 1:49 AM
$ABCL guess was correct multiple posts on x indicate phase 2 data is leaked and bad
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 21 at 12:26 AM
$ABCL AbCellera just appointed two new directors. Their stocks options have an exercise price of $7.85 As an outsider, you can buy $ABCL at a lower price than these two insiders on the open market
0 · Reply
_StockRadars
_StockRadars Jul. 20 at 11:15 PM
$ABCL why dip ?
2 · Reply
Alpha_Owl
Alpha_Owl Jul. 20 at 11:02 PM
$ABCL Target Zone & Price Action We warned you. Price is sliding straight toward our projected target zone of $5.58 - $3.96. We are sitting back and waiting for the market to complete the flush. After-Hours Analysis Following today's regular session close at $5.80, after-hours trading shows tight stabilization around $5.80 - $5.82 on low volume. While the heavy selling pressure is pausing, technical momentum remains firmly bearish. Watch for a retest of the lower bound of our target zone before looking for any meaningful reversal setups. Closing bell is getting closer. Cash or fully invested? Good luck in the final hour.
0 · Reply
Odoji
Odoji Jul. 20 at 10:40 PM
$ABCL 💉
0 · Reply
SmartMoneyRadar
SmartMoneyRadar Jul. 20 at 10:29 PM
$ABCL is testing an important level here 👀 The stock is currently retesting the 50 MA, and this is the area where buyers need to show up. If this level holds and momentum starts building again, the next target I’m watching is the Wave 3 target around $10.19. No need to force the trade. I want to see confirmation from price action and volume before getting too aggressive. Watching closely to see if this turns into a continuation setup or just another bounce. What do you think? After-hours is active. Any earnings surprise today? Looking forward to your thoughts.
0 · Reply
Kaykay610
Kaykay610 Jul. 20 at 10:25 PM
$ABCL Just noise US imposes new 50% tariffs on some Canadian products - https://www.reuters.com/business/us-imposes-new-50-tariffs-canadian-products-2026-07-20/?utm_source=braze&utm_medium=notifications&utm_campaign=2025_engagement
1 · Reply
tradersunion353
tradersunion353 Jul. 20 at 10:20 PM
$ABCL 2 dollars by end of the month yiu guys can alot before phase 2 readout where this drops to cents
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jul. 20 at 9:52 PM
Stocks I’m Watching for Potential Additions Building a watchlist around long-term growth themes: $SPCX - Starship technology could open massive future opportunities $NVDA - The AI revolution still runs through NVIDIA’s ecosystem $NFLX - Valuation looks more attractive after recent moves $NBIS - Cloud infrastructure demand continues expanding $ABCL - AI could accelerate drug discovery and biotech innovation The biggest opportunities often come from companies positioned at the center of powerful long-term trends. Conviction + patience = staying prepared for the next move. I’m continuing to track key opportunities and potential setups. Make sure notifications are on so you don’t miss the next alert.
0 · Reply
Targhee
Targhee Jul. 20 at 8:44 PM
2 · Reply
tradersunion353
tradersunion353 Jul. 20 at 8:39 PM
$ABCL phase 2 data is leaked and bad?! 40% drop in 2 weeks.. thats some serious
0 · Reply
TradeIntelligence_
TradeIntelligence_ Jul. 20 at 8:30 PM
$ABCL Price is currently testing the 50MA support zone. This is a key moment- if buyers defend this level, the next upside target comes into focus: Wave 3 target: $10.19 Watching closely for confirmation. A successful hold here could set up the next leg higher, but losing support would change the structure.
0 · Reply
MinimalistKLine
MinimalistKLine Jul. 20 at 8:22 PM
$ABCL Retesting the 50 MA $ABCL is back testing its 50 MA support zone. What do you think? If it holds, next target is Wave 3 at $10.19. Watching closely the chart is building a story, the next chapter is coming. Price action first, headlines later.
0 · Reply
Samb2344
Samb2344 Jul. 20 at 8:03 PM
$ABCL hold the line
0 · Reply
Olivia_Strickland
Olivia_Strickland Jul. 20 at 7:41 PM
$ABCL grinding lower 8.5% to 5.92, these breakdowns can accelerate hard or dead-cat bounce. watching how it handles VWAP, no read on the driver yet. what level are you guys watching here on my fade list: https://tapeboard.com/go/st/research/ABCL?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=abcl-bk-dn-watch&utm_term=research
0 · Reply
Arcides
Arcides Jul. 20 at 7:09 PM
$ABCL 4.50?
3 · Reply
DeMampCamp
DeMampCamp Jul. 20 at 7:09 PM
$ABCL Nasty! I bet the fake longs that are flipping this are happy, but not I! Keeping this above the 50 day moving average sure would be nice, but we're right on it now, hope we can bounce back above $6 by close
0 · Reply
tradersunion353
tradersunion353 Jul. 20 at 7:02 PM
$ABCL Clowns how is that never ending pumping working adding loading gift from god sold my house to buy abcl those never ending fairytail pumping stories?? are you guys feeling the heat??
0 · Reply